NCT05476341 - A Phase I Clinical Trial of Bevacizumab Injection | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

April 6, 2017

Primary Completion Date

August 18, 2017

Study Completion Date

August 18, 2017

Conditions

Rectal CancerLung CancerOvarian CancerCervical CancerGlioblastoma

Interventions

DRUG

Bevacizumab injection

Recombinant humanized monoclonal antibody injection against human vascular endothelial growth factor

DRUG

Bevacizumab injection（Avastin）

Recombinant humanized monoclonal antibody injection against human vascular endothelial growth factor

Trial Locations (1)

Affiliated Hospital of Changchun University of Traditional Chinese Medicine, Changchun